Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome
Conditions: Lower Urinary Tract Symptoms; Overactive Bladder Syndrome Interventions: Drug: mitoquinol mesylate; Other: Placebo Sponsors: Iman Al-Naggar, PhD; National Institute on Aging (NIA); American Urological Association; Urology Care Foundation; Claude D. Pepper Older Americans Independence Center (OAIC) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
Comparison of the Efficacy of Transcutaneos Nerve Stimulations in Women With Idiopathic Overactive Bladder
Conditions: Urinary Bladder, Overactive Interventions: Other: Transcutaneous MPN stimulation (T-MPNS); Other: Transcutaneous tibial nerve stimulation (TTNS); Other: BT (Control group) Sponsors: Pamukkale University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
Usability Study of the FemPulse System
Conditions: Overactive Bladder Interventions: Device: FemPulse System Sponsors: FemPulse Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials
Clinical Trial for the Assessment of Safety, Usability and Efficacy of the Vixe Combination for OAB in Female Subjects
Conditions: Overactive Bladder Interventions: Combination Product: ViXe Xombination; Combination Product: Placebo + Sham Sponsors: Vensica Therapeutics Ltd.; Blueclinical, Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials
Impact of TTNS on Bladder Symptoms Among People With MS, A RCT
Conditions: Overactive Bladder Syndrome Interventions: Device: Active Transcutaneous Electrical Nerve Stimulation (TENS); Device: Sham Transcutaneous Electrical Nerve Stimulation (TENS) Sponsors: Hawra Al-Dandan Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Transvaginal Detrusor Nerve Radiofrequency Ablation for Treatment of Overactive Bladder
Conditions: Overactive Bladder Syndrome Interventions: Device: Device Morpheus8V Sponsors: InMode MD Ltd. Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Evaluation of Intradetrusor AbobotulinumtoxinA and IncobotulinumtoxinA in Women With Overactive Bladder
Conditions: Overactive Bladder Interventions: Drug: AbobotulinumtoxinA 300 UNT; Drug: IncobotulinumtoxinA 100 UNT; Drug: Lidocain; Other: placebo Sponsors: Niko Kavcic Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
Efficacies of Different Managements in Patients With Overactive Bladder With Stroke
Conditions: Incontinence, Urge; Stroke; Neurogenic Bladder Interventions: Device: Tibial Nerve Stimulation with TENS device; Behavioral: Pelvic muscle training exercise with bladder training Sponsors: Gaziler Physical Medicine and Rehabilitation Education and Research Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials
Percutaneous Nerve Evaluation Trial Time
Conditions: Urge Incontinence; Urgency-frequency Syndrome; Overactive Bladder Interventions: Procedure: Sacral neuromodulation Sponsors: University of Chicago; Allegheny Health Network; University of California, Irvine; Atrium Health Wake Forest Baptist; University of Texas; Brown University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials
Migraine Medication Effects on Urinary Symptoms
Conditions: Overactive Bladder; Bladder Pain Syndrome; Migraine Disorders; Overactive Bladder Syndrome; Overactive Detrusor; Migraine; Interstitial Cystitis Interventions: Drug: Ubrogepant; Drug: Rimegepant; Drug: Atogepant; Drug: Eptinezumab; Drug: Fremanezumab; Drug: Galcanezumab; Drug: Erenumab; Drug: Botulinum toxin A Sponsors: The Cleveland Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials
Effect of BT and PFET on Urinary Symptoms and Quality of Life in Patients With OABS
Conditions: Overactive Bladder Syndrome (OABS) Interventions: Other: Standard Patient Education; Other: bladder training; Other: pelvic floor exercise Sponsors: Hacettepe University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
Effect of Extended Release Torsemide in Patients With Congestive Heart Failure and Overactive Bladder
Conditions: Heart Failure; Overactive Bladder; Incontinence Interventions: Drug: Extended release torsemide; Drug: Immediate release torsemide; Drug: Extended release torsemide placebo; Drug: Immediate release torsemide placebo Sponsors: University of Texas Southwestern Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of Vitamin D in the Treatment of OAB-wet in Children
Conditions: Urinary Bladder, Overactive; Overactive Bladder; Urinary Incontinence, Urge Interventions: Behavioral: urotherapy; Drug: Solifenacin Succinate; Drug: Vitamin D3 Sponsors: Xing Liu Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
rTMS in Overactive Bladder
Conditions: Overactive Bladder; Overactive Bladder Syndrome; Urge Incontinence; Urgency-frequency Syndrome; Urinary Incontinence; Urinary Incontinence, Urge Interventions: Device: Transcranial Magnetic Stimulation Sponsors: The Methodist Hospital Research Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Management of OAB in Female Patients .
Conditions: Overactive Bladder Interventions: Drug: Solfenacin; Drug: Mirabegron; Drug: Tadalafil 5mg Sponsors: Elsayed Abdelhalim Elsayed Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 28, 2023 Category: Research Source Type: clinical trials
